Related Experiment Video
Updated: Apr 24, 2026
Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by Immunostaining
Published on: June 13, 2020
Modeling medulloblastoma pathogenesis and treatment in human cerebellar organoids
Thomas Willott1, James G Nicholson1, Xinyu Zhang1
1Brain Tumour Research Centre, Blizard Institute, Queen Mary University of London, London E1 2AT, United Kingdom.
Abstract:
Medulloblastoma (MB) groups 3 and 4 arise from human-specific developmental contexts that remain experimentally inaccessible, limiting mechanistic insight into tumor initiation. We generated cerebellar organoids (CbOs) from expanded potential stem cells (EPSCs) and performed integrated single-cell transcriptomic and DNA methylation analyses, revealing discrete human rhombic lip progenitor populations whose developmental programs align with group 3- and group 4-associated lineages. Using c-MYC overexpression as an initiating oncogenic event, we demonstrated that these lineage-restricted progenitors are susceptible to neoplastic transformation, generating tumors with group 3 MB molecular features in vitro and in vivo. We further established a CbO-MB coculture system that preserves malignant and nonmalignant cellular compartments, hence enabling interrogation of tumor-microenvironment interactions and providing simultaneous readouts of antitumor efficacy and cerebellar toxicity upon drug treatment. Receptor-ligand modeling in this system identifies TGFβ paracrine signaling as a microenvironmental pathway supporting MB growth, which we validated pharmacologically. Further analyses of cocultured MB cells revealed a myogenic differentiation program enriched in MYC-driven MB and recurrent disease, which is associated with poorer prognosis. Together, this work establishes a collection of CbO models for studying group 3/4 MB initiation, growth, and microenvironmental dependencies and provides a tractable platform for further mechanistic and therapeutic investigation of these tumors.
Insights
Researchers developed new cerebellar organoid models to study medulloblastoma (MB) initiation. These models revealed specific progenitor cells susceptible to MYC-driven transformation, offering insights into tumor development and therapeutic strategies.
Area of Science:
- Developmental biology
- Cancer research
- Stem cell biology
Background:
- Medulloblastoma (MB) groups 3 and 4 initiation is poorly understood due to limited experimental models of human-specific developmental contexts.
- Investigating early tumor development requires models that recapitulate human cerebellar development.
Purpose of the Study:
- To establish novel cerebellar organoid (CbO) models for studying the initiation and progression of human medulloblastoma groups 3 and 4.
- To identify progenitor populations and microenvironmental factors involved in MB tumorigenesis.
Main Methods:
- Generation of cerebellar organoids (CbOs) from expanded potential stem cells (EPSCs).
- Integrated single-cell transcriptomic and DNA methylation analyses.
- c-MYC overexpression to induce neoplastic transformation in progenitor cells.
- Development of a CbO-MB coculture system for studying tumor-microenvironment interactions.
Main Results:
- Identified discrete human rhombic lip progenitor populations linked to MB groups 3 and 4 lineages.
- Demonstrated neoplastic transformation of lineage-restricted progenitors by c-MYC, generating MB with group 3 features.
- Revealed TGFβ paracrine signaling as a key microenvironmental pathway supporting MB growth.
- Discovered a myogenic differentiation program in MYC-driven MB associated with poor prognosis.
Conclusions:
- Established CbO models provide a tractable platform for studying group 3/4 MB initiation, growth, and microenvironmental dependencies.
- These models facilitate mechanistic and therapeutic investigations of medulloblastoma.
- Identified MYC-driven myogenic differentiation as a potential biomarker and therapeutic target in MB.
